Baijiao An

678 total citations
31 papers, 555 citations indexed

About

Baijiao An is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Baijiao An has authored 31 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 13 papers in Organic Chemistry. Recurrent topics in Baijiao An's work include Cancer therapeutics and mechanisms (11 papers), Lung Cancer Treatments and Mutations (11 papers) and Synthesis and biological activity (9 papers). Baijiao An is often cited by papers focused on Cancer therapeutics and mechanisms (11 papers), Lung Cancer Treatments and Mutations (11 papers) and Synthesis and biological activity (9 papers). Baijiao An collaborates with scholars based in China, United States and Hong Kong. Baijiao An's co-authors include Xingshu Li, Ling Huang, Jun Yan, Jinhui Hu, Yanqing Pang, Sheng Yin, Junsheng Zhang, Lanlan Lou, Tingting Pan and Albert S. C. Chan and has published in prestigious journals such as ACS Applied Materials & Interfaces, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Baijiao An

30 papers receiving 547 citations

Peers

Countries citing papers authored by Baijiao An

Since Specialization

Citations

This map shows the geographic impact of Baijiao An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baijiao An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baijiao An more than expected).

Fields of papers citing papers by Baijiao An

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baijiao An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baijiao An. The network helps show where Baijiao An may publish in the future.

Co-authorship network of co-authors of Baijiao An

This figure shows the co-authorship network connecting the top 25 collaborators of Baijiao An. A scholar is included among the top collaborators of Baijiao An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baijiao An. Baijiao An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel fluorescent molecules based on coumarin–chalcone hybrids for visually detection of pH and their anticancer activities 2025 ·Inorganic Chemistry Communications ·Mei Han, (unknown), Yongqing Liu, Baijiao An, Chan Huang, Xiaohua Cai	1
2	HOGA1 Suppresses Renal Cell Carcinoma Growth via Inhibiting the Wnt/β‐Catenin Signalling Pathway 2025 ·Journal of Cellular and Molecular Medicine ·Congmin Wang, Yu Liu, Ying Xim Tan, Fuyi Xu, Mingyao Wang, Yiming Tang, Guiying Nie, (unknown), Zhaowei Xu, Yuxue Xu, Baijiao An, Tian Geng, (unknown), (unknown)	2
3	Improved chemical and gastrointestinal stability of natural proanthocyanidins encapsulated in hydrolyzed soy protein-based nanoparticles 2025 ·Food Research International ·Hongling Fu, Hao Gong, (unknown), Baijiao An, Xue Chen, Bin Liu, Bo Lyu, (unknown), Hansong Yu	0
4	Design, Synthesis and Evaluation of Novel Cyclopropanesulfonamide Derivatives for the Treatment of EGFRC797S Mutation in Non-Small Cell Lung Cancer 2025 ·Drug Design Development and Therapy ·Mengxuan Wang, (unknown), (unknown), Chunlong Wang, (unknown), Shuai Zhang, (unknown), Yang Yang, (unknown), Ling Xu, Baijiao An	1
5	Synthesis of novel deuterated EGFR/ALK dual-target inhibitors and their activity against non-small cell lung cancer 2024 ·European Journal of Medicinal Chemistry ·(unknown), Shuai Zhang, Lihan Wang, Mengxuan Wang, (unknown), (unknown), Xingshu Li, Geng Tian, Baijiao An	3
6	Inhibition of TGF-β1/Smad3 signaling by compound 5aa: A potential treatment for idiopathic pulmonary fibrosis 2024 ·Bioorganic Chemistry ·Baijiao An, (unknown), Lihan Wang, (unknown), Mengxuan Wang, (unknown), Chengjun Wu, Ruoyu Wang	2
7	The new N2, N4-diphenylpyridine-2,4-diamine deuterated derivatives as EGFR inhibitors to overcome C797S-mediated resistance 2024 ·Bioorganic Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mengxuan Wang, Xingshu Li, Baijiao An, Xian Jia	6
8	A novel c-Met/TRK inhibitor 1D228 efficiently inhibits tumor growth by targeting angiogenesis and tumor cell proliferation 2023 ·Cell Death and Disease ·Baijiao An, (unknown), Jinhui Hu, Yangyang Fan, (unknown), Mengxuan Wang, (unknown), Han Yao, Yuanyuan Ren, Chuanchuan Zhang, (unknown), (unknown), (unknown), Chunhua Yang, Yin Zhang, Xingshu Li, Geng Tian	10
9	Discovery of potent and effective inhibitors containing sulfoxide structures targeting EML4-ALK rearrangement and EGFR mutant non-small cell lung cancer 2023 ·Bioorganic Chemistry ·Baijiao An, Yangyang Fan, (unknown), (unknown), (unknown), Mengxuan Wang, Jie Feng, Han Yao, Yin Zhang, Xingshu Li, Geng Tian	10
10	A Multifunctional Vanadium-Iron-Oxide Nanoparticle Eradicates Hepatocellular Carcinoma via Targeting Tumor and Endothelial Cells 2022 ·ACS Applied Materials & Interfaces ·(unknown), Jianmin Xiao, Lingyu Jiang, (unknown), Yangyang Fan, Minghui Zhang, Yuxue Xu, (unknown), Baijiao An, Yang Yang, (unknown), Geng Tian, Guilong Zhang, Yin Zhang	22
11	Novel third-generation pyrimidines-based EGFR tyrosine kinase inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer 2022 ·Bioorganic Chemistry ·Baijiao An, Jian Liu, Yangyang Fan, (unknown), Chunhua Yang, (unknown), Wěi Li, Yin Zhang, Xingshu Li, Geng Tian	10
12	Synthesis and evaluation of novel 2,4-diaminopyrimidines bearing a sulfoxide moiety as anaplastic lymphoma kinase (ALK) inhibition agents 2021 ·Bioorganic & Medicinal Chemistry Letters ·Fengshi Wu, (unknown), Wei Li, Niuniu Zhang, Yangyang Fan, Albert S. C. Chan, Xingshu Li, Baijiao An	3
13	Design, synthesis and biological evaluation of novel 2,4-diaryl pyrimidine derivatives as selective EGFRL858R/T790M inhibitors 2020 ·European Journal of Medicinal Chemistry ·Jianheng Li, Baijiao An, (unknown), (unknown), Chun Chen, (unknown), Run‐Zhu Fan, Xingshu Li, Yong Zou	27
14	The discovery of a potent and selective third-generation EGFR kinase inhibitor as a therapy for EGFR L858R/T790M double mutant non-small cell lung cancer 2019 ·European Journal of Medicinal Chemistry ·Baijiao An, Tingting Pan, Jinhui Hu, Yanqing Pang, Ling Huang, Albert S. C. Chan, Xingshu Li, Jun Yan	23
15	Synthesis and Biological Evaluation of Selenium-Containing 4-Anilinoquinazoline Derivatives as Novel Antimitotic Agents 2018 ·Journal of Medicinal Chemistry ·Baijiao An, Bo Wang, Jinhui Hu, (unknown), Ling Huang, Xingshu Li, Albert S. C. Chan	53
16	Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors 2018 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Baijiao An, Yuxin Li, (unknown), Xingshu Li, Xian Jia	8
17	Evaluation of 4-phenylamino-substituted naphthalene-1,2-diones as tubulin polymerization inhibitors 2018 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Baijiao An, Xingshu Li, Wei Zeng	7
18	Synthesis and evaluation of clioquinol-rolipram/roflumilast hybrids as multitarget-directed ligands for the treatment of Alzheimer's disease 2018 ·European Journal of Medicinal Chemistry ·Jinhui Hu, Tingting Pan, Baijiao An, (unknown), Xingshu Li, Ling Huang	39
19	The synthesis and evaluation of new butadiene derivatives as tubulin polymerization inhibitors 2017 ·Bioorganic & Medicinal Chemistry ·Yanqing Pang, Jun Yan, Baijiao An, Ling Huang, Xingshu Li	13
20	Design, synthesis, and biological evaluation of cyclic-indole derivatives as anti-tumor agents via the inhibition of tubulin polymerization 2016 ·European Journal of Medicinal Chemistry ·Jun Yan, Jinhui Hu, Baijiao An, Li Huang, Xingshu Li	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact